Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f284ae515fa8c17efd48d90eed89bd1e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
filingDate |
2006-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39aa12f449ef84405b6bde349e61b146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ebdf6368ce84711d5ccb8cc1096d28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab9f699bb64ed3c016f242b579181ab6 |
publicationDate |
2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1894571-A1 |
titleOfInvention |
Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
abstract |
The present invention relates to the use of a modified interleukin 8 (IL-8) having increased GAG binding affinity and further inhibited or down-regulated biological activity compared to the respective wild type IL-8 for preparing a medicament for the prevention and/or treatment of ischemia reperfusion injury and/or transplant rejection in patients. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102596227-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029931-A1 |
priorityDate |
2006-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |